Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80,172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
Desai A, Smith CJ, Ashara Y, Orme JJ, Zanwar S, Potter A, Hocum C, Moffett JN, Schwecke AJ, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Molina J, Dimou A, Mansfield AS, Parikh K, Leventakos K. Desai A, et al. Among authors: zhao y. Clin Lung Cancer. 2023 Dec;24(8):689-695.e1. doi: 10.1016/j.cllc.2023.09.001. Epub 2023 Sep 17. Clin Lung Cancer. 2023. PMID: 37880074 Free article.
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.
Zhao Y, Foster NR, Meyers JP, Thomas SP, Northfelt DW, Rowland KM Jr, Mattar BI, Johnson DB, Molina JR, Mandrekar SJ, Schild SE, Bearden JD 3rd, Aubry MC, Adjei AA. Zhao Y, et al. J Thorac Oncol. 2015 Jan;10(1):172-80. doi: 10.1097/JTO.0000000000000383. J Thorac Oncol. 2015. PMID: 25247339 Free PMC article. Clinical Trial.
Emerging therapeutic agents for advanced non-small cell lung cancer.
Chen R, Manochakian R, James L, Azzouqa AG, Shi H, Zhang Y, Zhao Y, Zhou K, Lou Y. Chen R, et al. Among authors: zhao y. J Hematol Oncol. 2020 May 24;13(1):58. doi: 10.1186/s13045-020-00881-7. J Hematol Oncol. 2020. PMID: 32448366 Free PMC article. Review.
Immunotherapies targeting stimulatory pathways and beyond.
Marin-Acevedo JA, Kimbrough EO, Manochakian R, Zhao Y, Lou Y. Marin-Acevedo JA, et al. Among authors: zhao y. J Hematol Oncol. 2021 May 12;14(1):78. doi: 10.1186/s13045-021-01085-3. J Hematol Oncol. 2021. PMID: 33980266 Free PMC article. Review.
Crizotinib-associated renal cyst development may be associated with prolonged progression-free survival in patients with ALK-positive non-small-cell lung cancer: Case report and review of the literature.
Wiest NE, Tzou KS, Olson MT, Herchko SM, Bajalia EM, Thiel DD, Lou Y, Zhao Y, Manochakian R. Wiest NE, et al. Among authors: zhao y. Clin Case Rep. 2021 Jun 10;9(6):e04278. doi: 10.1002/ccr3.4278. eCollection 2021 Jun. Clin Case Rep. 2021. PMID: 34136235 Free PMC article.
80,172 results
You have reached the last available page of results. Please see the User Guide for more information.